Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-05-15
1989-11-07
Tarcza, John E.
Drug, bio-affecting and body treating compositions
Lymphokine
530387, 435 68, 43524027, 4351722, 935104, 935107, A61K 39395, C12N 500, C12N 1500, C12P 2100
Patent
active
048791121
ABSTRACT:
A monoclonal antibody against GnRH and particularly designated USASK/DSIL-GnRH is produced by a hybrid formed by fusion of cells from a myeloma line and antibody producing cells of the immune system from an animal previously immunized with a source of GnRH; the monoclonal antibody has the following characteristics:
REFERENCES:
patent: 4676981 (1987-06-01), Silversides et al.
Talwar et al, 2nd Int. Conference on Immunopharmacology ed, Hadden et al, Jun. 1983, pp. 415-420.
Arimura, A., L. Debeljuk, and A. V. Schally, Endocrinology 95: 323, 1974.
McCormack et al, Endocrinology, 100(3), pp. 633-667 (1977).
Shastri et al, Am. J. Reprod. Immunol. 1, pp. 262-265 (1981).
Siddle et al, Monoclonal Antibodies and Developments in Immunoassay, ed. Albertini (1981), pp. 53-66.
Lincoln et al, J. Reprod. Fert. 66, pp. 703-708 (1982).
Koch, Y. P. Chobsieng, U. Zor, M. Fridkin, and H. R. Lindner, Biochem Biophys Res. Commun 55: 623, 1973.
Kerdelhue, B., S. Catin, and M. Jutisz, In Motta, M., P. G. Crosignani, and L. Martini (eds.), Hypothalmic Hormones, Academic Press, London, 1975, p. 49.
Mapletoft Reuben J.
Misra Virkam
Murphy Bruce D.
Silversides David W.
Tarcza John E.
University of Saskatchewan
LandOfFree
Monoclonal antibodies agaisnt GnRH does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies agaisnt GnRH, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies agaisnt GnRH will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-82699